Press Releases - DiaGenic

02. May 2012

Journal of Alzheimer’s Disease awards Dr. Lönneborg and the team at DiaGenic for best scientific journal article in 2011

Read more about Journal of Alzheimer’s Disease awards Dr. Lönneborg and the team at DiaGenic for best scientific journal article in 2011

26. March 2012

DiaGenic and GE Healthcare to develop blood-based test for mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease

Read more about DiaGenic and GE Healthcare to develop blood-based test for mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease

08. February 2012

DiaGenic reports high 85% accuracy for blood based diagnosis in early Parkinson patients in European multicenter study

Read more about DiaGenic reports high 85% accuracy for blood based diagnosis in early Parkinson patients in European multicenter study

14. October 2011

Findings from DiaGenic, Pfizer R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer Disease

Read more about Findings from DiaGenic, Pfizer R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer Disease

17. December 2010

DiaGenic and Pfizer to collaborate on blood based biomarkers for early stages of Alzheimer’s disease

Read more about DiaGenic and Pfizer to collaborate on blood based biomarkers for early stages of Alzheimer’s disease

20. January 2010

DiaGenic and Ferrer inCode sign distribution agreement for breakthrough ADtect® early Alzheimer’s test in Western Europe and Latin America

Read more about DiaGenic and Ferrer inCode sign distribution agreement for breakthrough ADtect® early Alzheimer’s test in Western Europe and Latin America

17. April 2007

US-Scandinavian researchers present DiaGenic's Breast Cancer MDx prototype at AACR Late-Breaking sessions

Read more about US-Scandinavian researchers present DiaGenic's Breast Cancer MDx prototype at AACR Late-Breaking sessions

06. January 2006

Tildeling offentlige midler på NOK 9,76 mill

Read more about Tildeling offentlige midler på NOK 9,76 mill

20. December 2007

The Michael J. Fox Foundation funds DiaGenic's development of first Parkinson's blood test

Read more about The Michael J. Fox Foundation funds DiaGenic's development of first Parkinson's blood test

27. August 2004

The merger between DiaGenic and Mefjorden listed today

Read more about The merger between DiaGenic and Mefjorden listed today

09. January 2007

Statusrapport produkt prototyper

Read more about Statusrapport produkt prototyper

09. January 2007

Status Report on product prototypes

Read more about Status Report on product prototypes

08. April 2005

Rettet emisjon - økt utviklingstempo

Read more about Rettet emisjon - økt utviklingstempo

31. January 2006

Results - Alzheimer's disease

Read more about Results - Alzheimer's disease

31. January 2006

Resultater Alzheimers sykdom

Read more about Resultater Alzheimers sykdom

14. October 2009

Press statement from the Norwegian Research Council awarding DiaGenic with “Norway’s Most Innovative Company of the Year”

Read more about Press statement from the Norwegian Research Council awarding DiaGenic with “Norway’s Most Innovative Company of the Year”

05. May 2006

Presentation of research results Alzheimer's disease

Read more about Presentation of research results Alzheimer's disease

03. April 2006

Presentasjon forskningsresultater brystkreft

Read more about Presentasjon forskningsresultater brystkreft

04. July 2006

Presentasjon forskningresultater brystkreft

Read more about Presentasjon forskningresultater brystkreft

08. December 2004

Patent i Norge

Patent i Europa

Opaldia to launch breast cancer blood test in 2008

Read more about Opaldia to launch breast cancer blood test in 2008

28. September 2006

Ny Toppsjef i DiaGenic ASA

Read more about Ny Toppsjef i DiaGenic ASA

21. September 2009

Ny blodbasert test oppdager Alzheimer's sykdom

Read more about Ny blodbasert test oppdager Alzheimer's sykdom

10. June 2007

New studies suggest early Alzheimer's detection by gene "signature" in blood or combined MRI/PET analysis

Read more about New studies suggest early Alzheimer's detection by gene "signature" in blood or combined MRI/PET analysis

28. September 2006

New Managing Director of DiaGenic ASA

Read more about New Managing Director of DiaGenic ASA

01. June 2007

New blood "signature" test holds key to successful early Alzheimer's diagnosis and treatment

Read more about New blood "signature" test holds key to successful early Alzheimer's diagnosis and treatment

03. April 2006

Molecular Discoveries Aim at Advancing Early Diagnosis of Cancers, AACR Press release

Read more about Molecular Discoveries Aim at Advancing Early Diagnosis of Cancers, AACR Press release

19. December 2007

Michael J. Fox Foundation Awards $2 Million To Continue Search For Biomarkers of Parkinson's Disease

Read more about Michael J. Fox Foundation Awards $2 Million To Continue Search For Biomarkers of Parkinson's Disease

27. February 2006

Market making avtale

Market making agreement

Leading International Alzheimer's experts join DiaGenic's scientific advisory board

Read more about Leading International Alzheimer's experts join DiaGenic's scientific advisory board

06. November 2006

Leading breast cancer experts join DiaGenic advisory board

Read more about Leading breast cancer experts join DiaGenic advisory board

27. August 2004

Fusjonen mellom DiaGenic og Mefjorden noteres idag

Read more about Fusjonen mellom DiaGenic og Mefjorden noteres idag

23. June 2009

DiaGenic to provide MCI biomarkers for Merz Pharmaceuticals

Read more about DiaGenic to provide MCI biomarkers for Merz Pharmaceuticals

14. December 2007

DiaGenic to partner with Opaldia in UK on blood based breast cancer gene expression test

Read more about DiaGenic to partner with Opaldia in UK on blood based breast cancer gene expression test

22. September 2005

DiaGenic present breakthrough Alzheimer's test data at IPA in Stockholm

Read more about DiaGenic present breakthrough Alzheimer's test data at IPA in Stockholm

28. October 2008

DiaGenic partners with DNAVision to offer first breast cancer and Alzheimer's gene expression blood tests

Read more about DiaGenic partners with DNAVision to offer first breast cancer and Alzheimer's gene expression blood tests

23. November 2005

DiaGenic has initiated discussions on breast cancer with bioMérieux

Read more about DiaGenic has initiated discussions on breast cancer with bioMérieux

16. March 2007

DiaGenic ASA presents prototypes of the first early bloodtest for Alzheimer's disease at AD/PD 2007

Read more about DiaGenic ASA presents prototypes of the first early bloodtest for Alzheimer's disease at AD/PD 2007

18. July 2006

DiaGenic ASA presents breakthrough data on development of the first early blood test for Alzheimer's disease at ICAD

Read more about DiaGenic ASA presents breakthrough data on development of the first early blood test for Alzheimer's disease at ICAD

14. June 2005

DiaGenic article on early breast cancer detection being published

Read more about DiaGenic article on early breast cancer detection being published

23. May 2008

DiaGenic appoints SRL RANBAXY Pathology Laboratories for marketing DiaGenic's early Breast Cancer Test in India

Read more about DiaGenic appoints SRL RANBAXY Pathology Laboratories for marketing DiaGenic's early Breast Cancer Test in India

18. October 2004

DiaGenic ansetter markedsdirektør

Read more about DiaGenic ansetter markedsdirektør

04. February 2008

DiaGenic announces preliminary results from a multicentre breast cancer study in India

Read more about DiaGenic announces preliminary results from a multicentre breast cancer study in India

10. November 2008

DiaGenic announces launch of first breast cancer gene-expression blood test

Read more about DiaGenic announces launch of first breast cancer gene-expression blood test

22. March 2005

Bekreftelser i vitenskapelige artikler - utvidet patent

Read more about Bekreftelser i vitenskapelige artikler - utvidet patent

02. March 2005

Bekreftelse kommersiell plattform

Read more about Bekreftelse kommersiell plattform

06. January 2006

Award of public funding of NOK 9,76 million

Read more about Award of public funding of NOK 9,76 million

13. March 2007